Additional file 5 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

Name: Additional file 5 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
Creator: Tang, Xiaowen; Cai, Mengjie; Ma, Yunju; Cui, Qingya; Liu, Lingling; Lian, Xiaying; Yin, Jia; Yu, Lei; Liu, Sining; Wu, Depei; Dai, Haiping; Kang, Liqing; Cui, Wei
Published: 2023-04-13T00:00:00+08:00